Avea Life is a technology company.
Avea Life has raised $3.0M across 1 funding round.
Avea Life has raised $3.0M in total across 1 funding round.
Avea Life has raised $3.0M in total across 1 funding round.
Avea Life's investors include Roland Brack.
Avea Life is a Swiss-based technology company specializing in science-backed longevity supplements designed to enhance cellular health, energy, skin rejuvenation, and mental clarity. Their product range focuses on supporting natural collagen production, balancing blood sugar, and providing antioxidant benefits to help individuals age healthily and gracefully. Avea primarily serves health-conscious consumers in Europe and Asia-Pacific (APAC), leveraging direct-to-consumer online sales and expanding through trusted retail channels. The company has demonstrated strong growth momentum, with year-on-year sales growth exceeding 400%, particularly fueled by successful market entry in China, Japan, and Singapore[1][2][3].
Founded in 2021 by Pascal Rode, Sophie Chabloz, and Teresa Budetta, Avea Life emerged from a vision to create evidence-based supplements grounded in cutting-edge longevity science. The founders, with scientific and entrepreneurial backgrounds, developed their first formulations in Switzerland, collaborating with leading experts and institutions such as ETH Zurich. Early traction came with the launch of their first products in February 2022, which combined the latest research on aging hallmarks with high-quality ingredients. The company quickly gained recognition for its patent-pending Collagen Activator and NMN (Nicotinamide mononucleotide) supplements, which have been well received in both European and Asian markets[2][3][4].
Avea rides the growing global trend of healthy aging and longevity science, a sector increasingly driven by advances in biotechnology, personalized health, and preventative medicine. The timing is favorable due to rising consumer demand for products that go beyond traditional wellness supplements to target the biological mechanisms of aging. Market forces such as aging populations in Europe and Asia, increased health awareness, and digital commerce growth support Avea’s expansion. By integrating scientific rigor with innovative product development and digital marketing, Avea influences the broader ecosystem by setting higher standards for efficacy and transparency in longevity supplements[1][2][4].
Avea is well-positioned to capitalize on the accelerating longevity market, with plans to deepen clinical research tailored to Asian populations and broaden retail partnerships. Future trends shaping their journey include personalized nutrition, integration of digital health monitoring, and further biotechnological innovations in aging. As consumer interest in evidence-based longevity solutions grows, Avea’s influence may expand from a niche supplement provider to a key player in the global healthy aging movement, potentially driving new standards for supplement efficacy and safety. Their continued focus on scientific collaboration and market expansion suggests a promising trajectory in both innovation and commercial success[2][4].
Avea Life has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in May 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2022 | $3.0M Seed | Roland Brack |